Camp4 Therapeutics Corp（CAMP）内部人交易：高管与董事近期交易
过去 18 个月，共有 21 位内部人为 Camp4 Therapeutics Corp（CAMP）报告了 39 笔 Form 4 交易（最近一笔 2026-09-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-02 | Gold Kelly | Chief Financial Officer | 买入 | 10,000 | $39,600 |
| 2026-08-31 | Schwab Andrew J. | 董事 | 卖出 | 400,000 | $1.6M |
| 2026-08-26 | Schwab Andrew J. | 董事 | 卖出 | 10 | $45 |
| 2026-08-21 | Schwab Andrew J. | 董事 | 卖出 | 45,147 | $214,900 |
| 2026-08-21 | Schwab Andrew J. | 董事 | 卖出 | 114,700 | $520,738 |
| 2026-08-21 | Schwab Andrew J. | 董事 | 卖出 | 32,018 | $144,081 |
| 2026-08-19 | Tardiff Daniel | Chief Scientific Officer | 卖出 | 1,738 | $8,273 |
| 2026-08-05 | Young Richard A | 董事 | 买入 | 16,378 | $27,024 |
| 2026-08-05 | Maricich Yuri | Chief Medical Officer | 买入 | 6,551 | $10,809 |
| 2026-08-05 | Mandel-Brehm Josh | Chief Executive Officer | 买入 | 6,551 | $10,809 |
| 2026-08-05 | Gold Kelly | Chief Financial Officer | 买入 | 6,551 | $10,809 |
| 2025-09-15 | PARMAR KUSH | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Ventures VI, L.P. | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Partners VI, LLC | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Opportunities II, L.P. | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Ventures VII, L.P. | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Opportunities II (GP), LLC | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | 5AM Partners VII, LLC | 10% 以上股东 | 买入 | 2.9M | $4.5M |
| 2025-09-15 | Schwab Andrew J. | 董事 | 买入 | 2.9M | $4.5M |
| 2025-09-11 | Young Richard A | 董事 | 买入 | 15,151 | $24,999 |
| 2025-09-11 | Gold Kelly | Chief Financial Officer | 买入 | 6,060 | $9,999 |
| 2025-09-11 | Nashat Amir | 董事 | 买入 | 1.2M | $1.9M |
| 2025-09-11 | Nashat Amir | 董事 | 买入 | 85,468 | $130,766 |
| 2025-09-11 | Chee Brian | 10% 以上股东 | 买入 | 1.2M | $1.9M |
| 2025-09-11 | SCHULMAN AMY W | 10% 以上股东 | 买入 | 1.2M | $1.9M |
来源：SEC Form 4 申报文件 · 截至 2026-09-02